Floatz logo

Seroquel®

Substance Abuse

Boston Medical CenterPhase 4 / ApprovedDormant
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Substance Abuse cohort.

Asset / SponsorPhaseRating
Seroquel®
Boston Medical Center
Phase 4BBB
Risperdal
Dartmouth-Hitchcock Medical Center
Phase 4BBB
Valproic Acid
Creighton University
Phase 4BB
Opc-34712
University of Massachusetts, Worcester
Phase 4BB
17.BETA.-(1-KETOETHYL)-.DELTA. SUP(5)-ANDROSTEN-3.BETA.-OL
University of Texas Southwestern Medical Center
Phase 4BB

View all 27 →

Same molecule, other indications

Seroquel® is also rated in:

substance abuseDormant
BBB
Indicative ·
78 / 100
View asset →
schizoaffective disorderDormant
BBB
Indicative ·
77 / 100
View asset →
mood disorderDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →